Tracey W R, Magee W, Masamune H, Kennedy S P, Knight D R, Buchholz R A, Hill R J
Department of Cardiovascular and Metabolic Diseases, Pfizer Inc., Groton, CT 06340, USA.
Cardiovasc Res. 1997 Feb;33(2):410-5. doi: 10.1016/s0008-6363(96)00240-4.
The aim of this study was to determine whether selective activation of the adenosine A3 receptor reduces infarct size in a Langendorff model of myocardial ischemia-reperfusion injury.
Buffer-perfused rabbit hearts were exposed to 30 min regional ischemia and 120 min of reperfusion. Infarct size was measured by tetrazolium staining and normalized for area-at-risk (IA/AAR).
Preconditioning by 5 min global ischemia and 10 min reperfusion reduced infarct size (IA/AAR) to 19 +/- 4% (controls: 67 +/- 5%). Replacing global ischemia with 5 min perfusion of the rabbit A3-selective agonist, IB-MECA (A3 Ki: 2 nM; A1 Ki: 30 nM) elicited a concentration-dependent reduction in infarct size; 50 nM IB-MECA reduced IA/AAR to 24 +/- 4%. The A1-selective agonist, R-PIA (25 nM) reduced IA/AAR to a similar extent (21 +/- 6%). However, while the cardioprotective effect of R-PIA was significantly inhibited (54 +/- 7% IA/AAR) by the rabbit A1-selective antagonist, BWA1433 (50 nM), the IB-MECA-dependent cardioprotection was unaffected (28 +/- 6% IA/AAR). A non-selective (A1 vs. A3) concentration of BWA1433 (5 microM) significantly attenuated the IB-MECA-dependent cardioprotection (61 +/- 7% IA/AAR).
These data clearly demonstrate that selective A3 receptor activation provides cardioprotection from ischemia-reperfusion injury in the rabbit heart. Furthermore, the degree of A3-dependent cardioprotection is similar to that provided by A1 receptor stimulation or ischemic preconditioning.
本研究旨在确定在心肌缺血-再灌注损伤的Langendorff模型中,腺苷A3受体的选择性激活是否能减小梗死面积。
用缓冲液灌注的兔心脏经历30分钟的局部缺血和120分钟的再灌注。通过四氮唑染色测量梗死面积,并将其标准化为危险区域面积(IA/AAR)。
5分钟全心缺血和10分钟再灌注预处理可将梗死面积(IA/AAR)减小至19±4%(对照组:67±5%)。用兔A3选择性激动剂IB-MECA(A3 Ki:2 nM;A1 Ki:30 nM)灌注5分钟替代全心缺血,可引起梗死面积的浓度依赖性减小;50 nM IB-MECA可将IA/AAR减小至24±4%。A1选择性激动剂R-PIA(25 nM)将IA/AAR减小至相似程度(21±6%)。然而,虽然兔A1选择性拮抗剂BWA1433(50 nM)可显著抑制R-PIA的心脏保护作用(IA/AAR为54±7%),但IB-MECA依赖的心脏保护作用未受影响(IA/AAR为28±6%)。非选择性(A1对A3)浓度的BWA1433(5 μM)可显著减弱IB-MECA依赖的心脏保护作用(IA/AAR为61±7%)。
这些数据清楚地表明,选择性激活A3受体可为兔心脏提供缺血-再灌注损伤的心脏保护作用。此外,A3依赖的心脏保护程度与A1受体刺激或缺血预处理提供的保护程度相似。